LATEST ARTICLES

8th Plenary Meeting EHDN 2014 Barcelona: 19-21 settembre 2014 – Report

Annarita Bentivoglio* - Marina Frontali** Si è appena concluso l’ottavo meeting plenario del Network Europeo per la Malattia di Huntington. Oltre 900 partecipanti: l’incontro più numeroso che sia stato mai organizzato sulla Malattia di Huntington. Un...

Fatal cellular malfunction identified in Huntington’s disease

Researchers believe they have learned how mutations in the gene that causes Huntington’s disease kill brain cells, a finding that could open new opportunities for treating the fatal disorder. Scientists first linked the gene...

New roles for huntingtin: removing a healthy protein to understand its function

This article was first published at en.hdbuzz.net Some techniques aimed at lowering mutant huntingtin can also affect the normal form of the protein. With clinical trials underway, it’s all the more important to understand the...

GLOBAL HUNTINGTON’S DISEASE PATIENT ADVOCACY ORGANIZATIONS UNITE TO FORM HUNTINGTON’S DISEASE COALITION FOR PATIENT...

This article was first published at www.hdsa.org The European Huntington Association (EHA), Huntington’s Disease Society of America (HDSA) and Huntington Society of Canada (HSC) are proud to announce the formation of the Huntington’s Disease Coalition...

BioSensics™ Has Received over $2.5M in Grant Funding from the NIH to Develop a...

BioSensics, a leader in developing wearable sensor technologies for clinical research and medical applications, has received grant funding from the National Institutes of Health (NIH) to develop HDWear, a novel telecare solution for Huntington’s disease. HDWear,...

George Yohrling, Ph.D Discusses Current and Potential HD Treatment Options

Since 2012, George Yohrling, PhD has served as the Senior Director, Mission and Scientific Affairs for the Huntington’s Disease Society of America (HDSA). In this video, he discusses current treatment options for patients, as...

C-Path, CHDI, and CDISC Announce Public Review for Huntington’s Disease Therapeutic Area User Guide

TUCSON, AZ, NEW YORK, NY, and AUSTIN, TX – September 11, 2017 – Critical Path Institute (C-Path), CHDI Foundation, Inc. (CHDI), and The Clinical Data Interchange Standards Consortium (CDISC) announce the availability of a draft Huntington’s disease (HD) Therapeutic Area...